San Francisco-based Spire Health announced on 14 July it closed a $38m equity financing, led by Gilde Healthcare Partners along with a leading global medtech strategic partner.
The company will use the funds to expand the commercialization of its respiratory remote patient monitoring platform, generate clinical and economic evidence, and invest in research and development.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?